Northern Trust’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,407
| Closed | -$9.42K | – | 4463 |
|
|
2023
Q4 | $9.42K | Buy |
1,407
+637
| +83% | +$4.26K | ﹤0.01% | 4423 |
|
|
2023
Q3 | $3.85K | Hold |
770
| – | – | ﹤0.01% | 4448 |
|
|
2023
Q2 | $7.66K | Hold |
770
| – | – | ﹤0.01% | 4493 |
|
|
2023
Q1 | $7.7K | Hold |
770
| – | – | ﹤0.01% | 4544 |
|
|
2022
Q4 | $16.9K | Hold |
770
| – | – | ﹤0.01% | 4517 |
|
|
2022
Q3 | $35K | Hold |
770
| – | – | ﹤0.01% | 4420 |
|
|
2022
Q2 | $43K | Hold |
770
| – | – | ﹤0.01% | 4448 |
|
|
2022
Q1 | $46K | Hold |
770
| – | – | ﹤0.01% | 4547 |
|
|
2021
Q4 | $75K | Hold |
770
| – | – | ﹤0.01% | 4506 |
|
|
2021
Q3 | $132K | Buy |
770
+128
| +20% | +$21.9K | ﹤0.01% | 4329 |
|
|
2021
Q2 | $105K | Hold |
642
| – | – | ﹤0.01% | 4353 |
|
|
2021
Q1 | $140K | Buy |
+642
| New | +$140K | ﹤0.01% | 4207 |
|